iTonis Inc. | Income Statement

Fiscal year is December-November. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
0.50
7.70
9.10
Cost of Goods Sold (COGS) incl. D&A
-
1.00
1.40
-
4.60
5.40
Gross Income
-
1.00
1.40
-
3.10
3.80
SG&A Expense
1,024.10
553.20
510.90
417.70
64.40
75.10
EBIT
1,025.20
554.30
512.30
-
61.30
71.30
Unusual Expense
259.20
6.20
7.80
1.90
322.40
0.10
Non Operating Income/Expense
-
608.40
-
-
-
-
Interest Expense
6.40
1.30
2.00
3.20
1.20
0.60
Pretax Income
772.40
1,170.20
506.50
422.70
384.90
71.80
Income Tax
0.80
0.80
0.80
-
0.80
-
Consolidated Net Income
773.20
1,169.40
507.30
422.70
385.70
71.80
Net Income
773.20
1,169.40
507.30
422.70
385.70
71.80
Net Income After Extraordinaries
773.20
1,169.40
507.30
422.70
385.70
71.80
Net Income Available to Common
773.20
1,169.40
507.30
422.70
385.70
71.80
EPS (Basic)
0.00
0.00
0.00
0.00
0.00
-
Basic Shares Outstanding
827,044.20
934,624.90
992,572.00
1,143,955.30
1,402,197.70
1,523,409.80
EPS (Diluted)
0.00
0.00
0.00
0.00
0.00
-
Diluted Shares Outstanding
827,044.20
934,624.90
992,572.00
1,143,955.30
1,402,197.70
1,523,409.80
EBITDA
1,024.10
553.20
510.90
417.30
61.30
71.30

About iTonis

View Profile
Address
22951 Mill Creek Drive
Laguna Hills California 92653
United States
Employees -
Website http://www.itonisholdings.com
Updated 07/08/2019
Itonis, Inc. operates as a holding company, which engages in development and distribution of products to the medical and pharmaceutical industry. Its product includes Emesyl. The company was founded on July 5, 2005 and is headquartered in Laguna Hills, CA.